CoChat

Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma

Open access
Cozzi, Luca, Comito, Tiziana, Fogliata, Antonella, Franzese, Ciro, Franceschini, Davide, Bonifacio, Cristiana, Tozzi, Angelo, Di Brina, Lucia, Clerici, Elena, Tomatis, Stefano, Reggiori, Giacomo, Lobefalo, Francesca, Stravato, Antonella, Mancosu, Pietro, Zerbi, Alessandro, Sollini, Martina, Kirienko, Margarita, Chiti, Arturo, Scorsetti, Marta · 2019 · PLOS ONE
Cited by 73

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

PURPOSE: To appraise the ability of a radiomics signature to predict clinical outcome after stereotactic body radiation therapy (SBRT) for pancreas carcinoma. METHODS: A cohort of 100 patients was included in this retrospective, single institution analysis. Radiomics texture features were extracted from computed tomography (CT) images obtained for the clinical target volume. The cohort of patients was randomly divided into two separate groups for the training (60 patients) and validation (40 patients). Cox regression models were built to predict overall survival and local control. The significant predictors at univariate analysis were included in a multivariate model. The quality of the models was appraised by means of area under the curve and concordance index. RESULTS: A clinical-radiomic signature associated with Overall Survival (OS) was found significant in both training and validation sets (p = 0.01 and 0.05 and concordance index 0.73 and 0.75 respectively). Similarly, a signature was found for Local Control (LC) with p = 0.007 and 0.004 and concordance index 0.69 and 0.75. In the low risk group, the median OS and LC in the validation group were 14.4 and 28.6 months while in the high-risk group were 9.0 and 17.5 months respectively. CONCLUSION: A CT based radiomic signature was identified which correlate with OS and LC after SBRT and allowed to identify low and high-risk groups of patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0210758

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 73

Metadata

Authors
Cozzi, L., Comito, T., Fogliata, A., Franzese, C., Franceschini, D., Bonifacio, C., Tozzi, A., Di Brina, L., Clerici, E., Tomatis, S., Reggiori, G., Lobefalo, F., Stravato, A., Mancosu, P., Zerbi, A., Sollini, M., Kirienko, M., Chiti, A., & Scorsetti, M.
Venue
PLOS ONE
Published
2019-01-18
Volume
14
Issue
1
Pages
e0210758
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2909986270
Cited by
73
References
2
FWCI
7.35
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma. https://app.cochat.ai/papers/10.1371/journal.pone.0210758
The paper
Cozzi, L., Comito, T., Fogliata, A., Franzese, C., Franceschini, D., Bonifacio, C., Tozzi, A., Di Brina, L., Clerici, E., Tomatis, S., Reggiori, G., Lobefalo, F., Stravato, A., Mancosu, P., Zerbi, A., Sollini, M., Kirienko, M., Chiti, A., & Scorsetti, M. (2019). Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0210758

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.